Novel role of very long chain fatty acids in the brain
Novel role of very long chain fatty acids in the brain
批准号:
8807392
负责人:
ROBERT E ANDERSON
金额:
$21.98万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-09-30 至 2016-08-31
关键词:
AdolescentAgeAnabolismAnimal ModelAreaBiochemicalBiochemical ReactionBiologicalBiological AssayBirthBrainCase StudyCeramidesCessation of lifeChildComplexDehydrationDevelopmentDiseaseElectrophysiology (science)Fatty AcidsFluorescence MicroscopyFunctional disorderGenesGenetically Engineered MouseHeartHippocampus (Brain)HourHumanIchthyosesIndividualInheritedIntellectual functioning disabilityKeratinLaboratoriesLeadLecithinLifeLinkLipidsLiverMacular degenerationMaintenanceMediatingMetabolismMusMutationNeurodegenerative DisordersNeuronsNeurophysiology - biologic functionOrganPatternPhenotypePlayPolyunsaturated Fatty AcidsRattusReportingResearchRetinaRetinal DegenerationRoleSaturated Fatty AcidsSeizuresSeriesSkinSliceSpastic TetraplegiaSphingolipidsStargardt&aposs diseaseStructureSynapsesTestingTestisTonic - clonic seizuresTransgenic MiceVery Long Chain Fatty AcidVisionbrain cellenhanced green fluorescent proteinglucose uptakehuman diseaseinvolucrinknockout animalmetabolomicsmouse modelmutantmyelinationneurodevelopmentneuromechanismneuropathologynovelpreventpromoterpublic health relevancepuprelating to nervous systemresearch study
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Our lab was the first to discover that ELOngation of Very Long chain fatty acids-4 (ELOVL4) is an elongase responsible for biosynthesis of very long chain (VLC; eC26) fatty acids that are found as components of more complex lipid molecules such as sphingolipids and phosphatidylcholine. ELOVL4 synthesizes the VLC polyunsaturated fatty acids (VLC-PUFA) found in retina and testes, and VLC saturated fatty acids (VLC-FA) in skin and brain. Heterozygous inheritance of mutant ELOVL4, which lacks the ability to synthesize these fatty acids, causes juvenile macular degeneration in autosomal dominant Stargardt's macular dystrophy (STGD3). Humans with homozygous inheritance of the STGD3 mutation (ELOVL4 mutant/mutant), and thus make no VLC- PUFA/VLC-FA, develop ichthyosis, seizures, intellectual disability, and spastic quadriplegia, and die within the first few years of ife. This establishes a causal link between the mutation in ELOVL4 to a neurodegenerative disease; other than that, nothing is known about the role and importance of VLC-FA in the brain. Our group showed that VLC-FA are in sphingolipids in the rat brain. We have successfully generated an animal model that recapitulates the human condition. This unique animal model will enable us to study the role of ELOVL4 and VLC-FA in neural cell development, structure and function, which is a novel and unexplored area of research. Our central hypothesis is that VLC-FA play an important role in the development/maintenance of as yet undescribed activities in the CNS and that mutations in ELOVL4 and/or loss of VLC-FA lead to impaired neural function, evident by hyper-excitability and seizures. This novel hypothesis and the studies proposed herein to test it will allow us to break new ground in understanding neural development and the biological role of ELOVL4 and its VLC-FA products in the brain. We propose the following three specific aims to test our hypothesis. In this R21 application, we propose a series of experiments that will provide us with the basic information we will need to submit an R01 application in the second year. 1. To test the hypothesis that a loss of VLC-FA within the CNS is sufficient to cause impaired neural development leading to neural dysfunction and seizures. 2. To characterize the expression pattern of ELOVL4 and its products within the CNS. 3. To determine the mechanism of neural dysfunction mediated by mutations in ELOVL4 and/or loss of VLC-FA.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Retinal Degeneration Conference
-
批准号:8495337
-
项目类别:
-
资助金额:$0.84万
-
财政年份:2012
-
负责人:ROBERT E ANDERSON
-
依托单位:
Retinal Degeneration Conference
-
批准号:8319141
-
项目类别:
-
资助金额:$7.81万
-
财政年份:2012
-
负责人:ROBERT E ANDERSON
-
依托单位:
Retinal Degeneration Conference
-
批准号:8690067
-
项目类别:
-
资助金额:$5.53万
-
财政年份:2012
-
负责人:ROBERT E ANDERSON
-
依托单位:
Retinal Degeneration Conference
-
批准号:8851604
-
项目类别:
-
资助金额:$0.84万
-
财政年份:2012
-
负责人:ROBERT E ANDERSON
-
依托单位:
COBRE: OUHSC: ADMINISTRATION, MENTORING, & RECRUITMENT CORE
-
批准号:8360402
-
项目类别:
-
资助金额:$126.29万
-
财政年份:2011
-
负责人:ROBERT E ANDERSON
-
依托单位:
P30-CENTER CORE GRANT FOR VISION RESEARCH
-
批准号:8479675
-
项目类别:
-
资助金额:$50.03万
-
财政年份:2011
-
负责人:ROBERT E ANDERSON
-
依托单位:
P30-CENTER CORE GRANT FOR VISION RESEARCH
-
批准号:8720773
-
项目类别:
-
资助金额:$55.13万
-
财政年份:2011
-
负责人:ROBERT E ANDERSON
-
依托单位:
P30-CENTER CORE GRANT FOR VISION RESEARCH
-
批准号:8152006
-
项目类别:
-
资助金额:$59.2万
-
财政年份:2011
-
负责人:ROBERT E ANDERSON
-
依托单位:
P30-Center Core Grant for Vision Research
-
批准号:9346075
-
项目类别:
-
资助金额:$59.2万
-
财政年份:2011
-
负责人:ROBERT E ANDERSON
-
依托单位:
P30-CENTER CORE GRANT FOR VISION RESEARCH
-
批准号:8527789
-
项目类别:
-
资助金额:$56.52万
-
财政年份:2011
-
负责人:ROBERT E ANDERSON
-
依托单位:
P30-CENTER CORE GRANT FOR VISION RESEARCH
-
批准号:8898812
-
项目类别:
-
资助金额:$53.68万
-
财政年份:2011
-
负责人:ROBERT E ANDERSON
-
依托单位:
P30-CENTER CORE GRANT FOR VISION RESEARCH
-
批准号:8319330
-
项目类别:
-
资助金额:$57.88万
-
财政年份:2011
-
负责人:ROBERT E ANDERSON
-
依托单位:
P30-CENTER CORE GRANT FOR VISION RESEARCH
-
批准号:8887692
-
项目类别:
-
资助金额:$14.82万
-
财政年份:2011
-
负责人:ROBERT E ANDERSON
-
依托单位:
Administrative Core
-
批准号:10011810
-
项目类别:
-
资助金额:$3.28万
-
财政年份:2011
-
负责人:ROBERT E ANDERSON
-
依托单位:
COBRE: OUHSC: ADMINISTRATION, MENTORING, & RECRUITMENT CORE
-
批准号:8168346
-
项目类别:
-
资助金额:$53.3万
-
财政年份:2010
-
负责人:ROBERT E ANDERSON
-
依托单位:
Retinal Degeneration Conference
-
批准号:7907375
-
项目类别:
-
资助金额:$6.93万
-
财政年份:2010
-
负责人:ROBERT E ANDERSON
-
依托单位:
Mentoring Vision Research In Oklahoma
-
批准号:7897994
-
项目类别:
-
资助金额:$100.0万
-
财政年份:2009
-
负责人:ROBERT E ANDERSON
-
依托单位:
COBRE: OUHSC: ADMINISTRATION, MENTORING, & RECRUITMENT CORE
-
批准号:7959972
-
项目类别:
-
资助金额:$45.14万
-
财政年份:2009
-
负责人:ROBERT E ANDERSON
-
依托单位:
Retinal Degeneration Conference
-
批准号:7483418
-
项目类别:
-
资助金额:$6.83万
-
财政年份:2008
-
负责人:ROBERT E ANDERSON
-
依托单位:
COBRE: OUHSC: ADMINISTRATION, MENTORING, & RECRUITMENT CORE
-
批准号:7720535
-
项目类别:
-
资助金额:$52.46万
-
财政年份:2008
-
负责人:ROBERT E ANDERSON
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: